Two-thirds in new ballot say abortion capsule ought to stay accessible

Two-thirds of People in a brand new ballot launched on Tuesday stated that mifepristone, one in every of two medicine utilized in treatment abortions, ought to stay in the marketplace.

The Washington Post-ABC News poll discovered that 66 % supported preserving in the marketplace, whereas 24 % supported taking the treatment off the market.

Amongst those that stated mifepristone ought to stay accessible, 72 % stated entry ought to stay the identical as it’s now. One other 18 % stated it must be extra restricted, the ballot discovered.

The ballot comes as mifepristone stays on the heart of a authorized battle, after a Texas federal choose final month suspended the Meals and Drug Administration’s (FDA) 23-year-old approval of the treatment.

The Supreme Courtroom put the ruling on hold because the Biden administration appeals the choice, leaving entry to mifepristone unchanged in the intervening time.

One other 66 % in Tuesday’s ballot stated they opposed the excessive courtroom’s choice final June to overturn Roe v. Wade and get rid of the constitutional proper to abortion, with 54 % saying they strongly opposed the choice.

Greater than three-quarters — 78 % — additionally stated the choice of whether or not a lady can have an abortion must be left to the girl and her physician, whereas simply 18 % stated it must be regulated by legislation.

The Washington Submit-ABC Information ballot was performed between April 28 and Could 3 with 1,006 adults responding. The survey had a margin of error of three.5 proportion factors.